drugset / Trial / NCT03269435

Greater Occipital Nerve Block Versus Metoclopramide

NCT03269435

Phase 4 Completed 99 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We are comparing a type of nerve block called greater occipital nerve block versus standard therapy among patients who present to an emergency department for acute migraine. This is a randomized, double-blind, double dummy study. The greater occipital nerve block will be performed bilaterally with bupivacaine 0.5%. Standard therapy is metoclopramide 10mg IV.

Timeline

Start
2017-11-01
Primary completion
2020-03-21
Completion
2020-03-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg Intravenous

Indications